#United States #Eagan #Sonex Health #UltraGuideCTR #Carpal Tunnel

Sonex Health's Pioneering Study in Carpal Tunnel Release

Introduction

In a significant advancement for outpatient surgical procedures, Sonex Health, Inc. and The Institute of Advanced Ultrasound Guided Procedures have released findings from the largest study focused on ultrasound-guided carpal tunnel release (UGCTR). This comprehensive investigation, which includes data from a two-year follow-up, highlights the effectiveness and safety of performing this procedure in an office setting using UltraGuideCTR™. The results were published in the reputable journal Plastic and Reconstructive Surgery – Global Online and stand as a testament to the efficacy of this innovative approach.

Study Overview

The study, dubbed ROBUST, served as a multicenter, prospective trial that evaluated 149 patients and 226 hands treated with UGCTR procedures. Key facets of the trial included execution across seven U.S. centers, comprising five private practices and two academic institutions. Remarkably, patient procedures were carried out using only local anesthesia, making it a less invasive option. With an impressive 92% follow-up rate at two years, the study provides robust long-term data supporting the procedure's benefits.

Key Findings

The data yielded compelling results regarding patient outcomes:

• - Symptom Improvement: Patients reported rapid symptom relief within two weeks. These effects continued to be beneficial for up to two years post-procedure.
• - Recovery Time: Patients typically resumed daily activities within just two days, while returning to work took around four days.
• - Patient Satisfaction: Remarkably, the procedure garnered a satisfaction rate peaking at 95.7% after two years, indicating a high success rate in patient experience.
• - Procedure Safety: All treatments were performed in a clinic setting under local anesthesia, without instances of unmanageable symptoms necessitating further revisions.
• - Bilateral Procedures: Notably, 52% of the patients underwent bilateral procedures, and outcomes showed similar safety and effectiveness across both unilateral and bilateral approaches.

Expert Insights

Dr. Ashley Pistorio, the study's principal investigator and associate professor at the University of Nevada, reflects on its implications stating, _"This important study demonstrated ultrasound-guided carpal tunnel release can be performed safely and effectively in an office setting, making this treatment option more accessible and convenient to patients across the U.S."_ Her personal experience with the procedure further illustrates its potential benefits for patients.

Economic and Healthcare Implications

President and CEO of Sonex Health, Bob Paulson, reiterated the significance of UGCTR, emphasizing its role in transforming clinical outcomes and enhancing patient care while simultaneously controlling healthcare costs. The study aligns with a growing trend toward office-based procedures, which offer immediate access, minimal recovery time, and reduced overhead compared to traditional facility-based alternatives.

Conclusion

Sonex Health’s findings underscore a paradigm shift in the treatment of carpal tunnel syndrome, as the UGCTR technique stands out for its efficacy, safety, and patient satisfaction. These results, combined with the increasing body of peer-reviewed studies, will serve to inform patients, providers, and healthcare payors alike. Ultimately, the future of outpatient carpal tunnel treatment appears bright, heralding advancements in minimally invasive surgical practices that prioritize patient-centered care.

For more information about Sonex Health and its innovative products, visit SonexHealth.com.